<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-12T16:27:26Z</responseDate>
  <request identifier="oai:figshare.com:article/34048235" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34048235</identifier>
        <datestamp>2026-10-01T17:31:19Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_7</setSpec>
        <setSpec>category_8</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_16</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_1</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Representative hematoxylin and eosin-stained nasal mucosal sections from all experimental groups.&lt;/p&gt;</dc:title>
          <dc:creator>Naim Gheymoumi (25157753)</dc:creator>
          <dc:creator>Sevda Shayesteh (25157756)</dc:creator>
          <dc:creator>Fatemeh Sharifi (3496619)</dc:creator>
          <dc:creator>Marziyeh Amiri-Andebili (25157759)</dc:creator>
          <dc:creator>Hediyeh Gheymoumi (25157762)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Microbiology</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Physiology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>potential immunometabolic modulator</dc:subject>
          <dc:subject>following ova sensitization</dc:subject>
          <dc:subject>endogenous tryptophan metabolite</dc:subject>
          <dc:subject>elevated serum ige</dc:subject>
          <dc:subject>aryl hydrocarbon receptor</dc:subject>
          <dc:subject>serum inflammatory markers</dc:subject>
          <dc:subject>including increased sneezing</dc:subject>
          <dc:subject>mucosal immune regulation</dc:subject>
          <dc:subject>systemic inflammatory mediators</dc:subject>
          <dc:subject>study investigated kyna</dc:subject>
          <dc:subject>findings support kyna</dc:subject>
          <dc:subject>marked inflammatory changes</dc:subject>
          <dc:subject>xlink "&gt; rats</dc:subject>
          <dc:subject>local regulatory cytokines</dc:subject>
          <dc:subject>ar remain unclear</dc:subject>
          <dc:subject>systemic effects comparable</dc:subject>
          <dc:subject>ahr signaling contributes</dc:subject>
          <dc:subject>xlink "&gt;</dc:subject>
          <dc:subject>regulatory cytokines</dc:subject>
          <dc:subject>systemic anti</dc:subject>
          <dc:subject>inflammatory infiltration</dc:subject>
          <dc:subject>histopathological changes</dc:subject>
          <dc:subject>inflammatory effects</dc:subject>
          <dc:subject>cytokine regulation</dc:subject>
          <dc:subject>associated regulation</dc:subject>
          <dc:subject>ahr signaling</dc:subject>
          <dc:subject>kyna ),</dc:subject>
          <dc:subject>splenic tissues</dc:subject>
          <dc:subject>splenic histopathology</dc:subject>
          <dc:subject>kynurenic acid</dc:subject>
          <dc:subject>indicating involvement</dc:subject>
          <dc:subject>immunomodulatory properties</dc:subject>
          <dc:subject>greater improvement</dc:subject>
          <dc:subject>epithelial damage</dc:subject>
          <dc:subject>behavioral responses</dc:subject>
          <dc:subject>associated proteins</dc:subject>
          <dc:description>&lt;p&gt;(Edema: o; eosinophilic infiltrate: arrows; abnormal epithelium: asterisk). The AR group showed marked epithelial disruption, submucosal edema, and inflammatory cell infiltration compared with the control group. KYNA and desloratadine treatment attenuated these histopathological alterations. Samples include (A) Control, (B) AR, (C) Al(OH)&lt;sub&gt;3&lt;/sub&gt;, (D) KYNA, and (E) desloratadine groups. All images were obtained at ×40 magnification.&lt;/p&gt;</dc:description>
          <dc:date>2026-10-01T17:31:10Z</dc:date>
          <dc:type>Image</dc:type>
          <dc:type>Figure</dc:type>
          <dc:identifier>10.1371/journal.pone.0359624.g004</dc:identifier>
          <dc:relation>https://figshare.com/articles/figure/_p_Representative_hematoxylin_and_eosin-stained_nasal_mucosal_sections_from_all_experimental_groups_p_/34048235</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
